Free Trial
Ends Tomorrow! Last Chance to Save $100 on MarketBeat All Access
  • 0Days
  • 0Hours
  • 0Minutes
  • 0Seconds
Claim $100 Off
Claim MarketBeat All Access Sale Promotion
Allen Gong

Allen Gong Analyst Performance

Vice President, Equity Research at JPMorgan Chase & Co.

Allen Gong is a stock analyst at JPMorgan Chase & Co. in the medical sector, covering 6 publicly traded companies. Over the past year, Allen Gong has issued 12 stock ratings, including buy and hold recommendations. While full access to Allen Gong's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Allen Gong's coverage history, rating activity, and performance tendencies — helping individual investors make more informed trading decisions.

Analyst Rankings, Coverage, and Performance Statistics

Average Return
00.00% 12-Month ROI
Success Rate
00.00% Profitable Ratings
Total Ratings
12 Last 0 Years
Buy Recommendations
83.33% 10 Buy Ratings
Companies Covered
6 Unique Companies

Ratings Distribution

RatingPercentageCount
Strong Buy0.0%0 ratings
Buy83.3%10 ratings
Hold16.7%2 ratings
Sell0.0%0 ratings

Out of 12 total stock ratings issued by Allen Gong at JPMorgan Chase & Co., the majority (83.3%) have been Buy recommendations, followed by 16.7% Hold.

Best & Worst Calls

This analyst does not have any ratings with enough history to determine best and worst calls.

Exchange Coverage

ExchangePercentageCount
NASDAQ
66.7% of companies on NASDAQ
4 companies
NYSE
33.3% of companies on NYSE
2 companies

Allen Gong, an analyst at JPMorgan Chase & Co., currently covers 6 companies listed on NASDAQ and NYSE, with the majority traded on NASDAQ.

Coverage Focus

Sector IconSectorPercentage
Medical
6 companies
100.0%

Allen Gong of JPMorgan Chase & Co. specializes in stock coverage within the Medical sector.

Coverage Industries

IndustryPercentage
MED INSTRUMENTS
3 companies
50.0%
MED PRODUCTS
1 company
16.7%
MEDICAL INFO SYS
1 company
16.7%
MEDICAL SERVICES
1 company
16.7%

Allen Gong's Ratings History at JPMorgan Chase & Co.

Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.
Available with a MarketBeat All Access Subscription
12-Month ROIUpgrade to All Access to use the All ROI Filter
CompanyReport DateActionReport Date Price12-Month
Price Target
Rating12-Month
Price & ROI
Details
Haemonetics Corporation stock logo
HAE
Haemonetics
5/8/2026Lower Price Target$55.36$62.00Neutral
Alphatec Holdings, Inc. stock logo
ATEC
Alphatec
5/6/2026Lower Price Target$6.99$16.00Overweight
iRhythm Technologies stock logo
IRTC
iRhythm Technologies
5/1/2026Lower Price Target$118.39$175.00Overweight
Glaukos Corporation stock logo
GKOS
Glaukos
4/30/2026Boost Price Target$142.95$140.00Overweight
TransMedics Group, Inc. stock logo
TMDX
TransMedics Group
2/25/2026Boost Price Target$133.26$149.00Neutral
iRhythm Technologies stock logo
IRTC
iRhythm Technologies
2/20/2026Lower Price Target$150.42$215.00Overweight
Establishment Labs Holdings Inc. stock logo
ESTA
Establishment Labs
12/17/2025Boost Price Target$74.20$80.00Overweight
Establishment Labs Holdings Inc. stock logo
ESTA
Establishment Labs
11/6/2025Boost Price Target$64.91$71.00Overweight
iRhythm Technologies stock logo
IRTC
iRhythm Technologies
10/31/2025Boost Price Target$187.40$240.00Overweight
Glaukos Corporation stock logo
GKOS
Glaukos
10/30/2025Boost Price Target$88.21$120.00Overweight
Alphatec Holdings, Inc. stock logo
ATEC
Alphatec
10/24/2025Initiated Coverage$15.89$19.00Overweight
iRhythm Technologies stock logo
IRTC
iRhythm Technologies
8/1/2025Boost Price Target$167.16$190.00Overweight